Argatroban is a direct thrombin inhibitor that binds the active site of thrombin independent of antithrombin, used as an alternative anticoagulant in patients with heparin-induced thrombocytopenia. Simson Pharma's Argatroban reference standard and impurities support the precise potency control required of this critical-care injectable anticoagulant.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Argatroban Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.